On June 7, 2022, Raymond Cheong, M.D., Ph.D., notified Talis Biomedical Corporation (the Company) of his resignation from his position as a member of the Company's Board of Directors (the Board) and as a member of the Science, Technology and Clinical Affairs Committee of the Board, effective immediately prior to the Company's 2022 Annual Meeting of the Stockholders held on June 10, 2022 (the Annual Meeting). Dr. Cheong's departure is to ensure the Company's continued compliance with Nasdaq Listing Rule 5605(b), which requires that a majority of the Board be comprised of independent directors (as defined in Nasdaq Listing Rule 5605(a)(2)) and is not a result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.14 USD | +1.56% | +2.70% | +22.68% |
Apr. 02 | North American Morning Briefing : Stocks Seen -2- | DJ |
Mar. 28 | Talis Biomedical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+22.68% | 16.65M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- TLIS Stock
- News Talis Biomedical Corporation
- Talis Biomedical Corporation Announces Resignation of Raymond Cheong from Board of Directors